Arsenic in drinking water and urinary tract cancers: A systematic review of 30 years of epidemiological evidence

Environmental Health: A Global Access Science Source

Volumn 13, Issue 1, 2014, Pages

  Saint Jacques, Nathalie ^a,b   Parker, Louise ^b   Brown, Patrick ^c   Dummer, Trevor Jb ^b  

^a Cancer Care Nova Scotia   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Population Studies and Surveillance   (Canada)

Author keywords

Arsenic; Bladder; Cancer risk; Drinking water; Kidney; Meta analysis; Systematic review; Urinary tract

Indexed keywords

ARSENIC; DRINKING WATER; WATER POLLUTANT;

ARSENIC; BOOTSTRAPPING; CANCER; CONCENTRATION (COMPOSITION); DISEASE INCIDENCE; DRINKING WATER; EPIDEMIOLOGY; HEALTH IMPACT; HEALTH RISK; META-ANALYSIS; MORTALITY; POLLUTION EXPOSURE; PUBLIC HEALTH; RISK FACTOR; TEMPORAL PERIOD;

ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; HUMAN; KIDNEY CANCER; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; CHEMISTRY; KIDNEY NEOPLASMS; TOXICITY; URINARY BLADDER NEOPLASMS; WATER POLLUTANT;

ARSENIC; DRINKING WATER; HUMANS; KIDNEY NEOPLASMS; URINARY BLADDER NEOPLASMS; WATER POLLUTANTS, CHEMICAL;

EID: 84904254734     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-13-44     Document Type: Article

References (107)

1. Arsenic round the world: a review. Mandal BK, Suzuki KT, Talanta 2002 58 201 235 (Pubitemid 34857394)
2. A review of the source, behaviour and distribution of arsenic in natural waters. Smedley PL, Kinniburgh DG, Appl Geochem 2002 17 517 568 (Pubitemid 34290137)
3. IARC, Arsenic in drinking-water Lyon: International Agency for Research on Cancer 2004 267
4. Arsenic in the environment: effects on human health and possible prevention. Singh N, Kumar D, Sahu AP, J Environ Biol 2007 28 359 365 (Pubitemid 46683616)
5. Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Cantor KP, Lubin JH, Toxicol Appl Pharmacol 2007 222 252 257 (Pubitemid 47214560)
6. Comparison of drinking water, raw rice and cooking of rice as arsenic exposure routes in three contrasting areas of West Bengal, India. Mondal D, Banerjee M, Kundu M, Banerjee N, Bhattacharya U, Giri AK, Ganguli B, Sen Roy S, Polya DA, Environ Geochem Health 2010 32 463 477
7. Cancers related to exposure to arsenic at a copper smelter. Enterline PE, Day R, Marsh GM, Occup Environ Med 1995 52 28 32
8. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. Liu J, Zheng B, Aposhian HV, Zhou Y, Chen M-L, Zhang A, Waalkes MP, Environ Health Perspect 2002 110 119 122 (Pubitemid 34163025)
9. Bladder Cancer. Silverman D, Deveda S, Moore L, Rothman N, Cancer Epidemiology and Prevention New York: Oxford University Press 2006 1101 1127
10. World Health Organization, Arsenic, Fact sheet N°372, December 2012 http://www.who.int/mediacentre/factsheets/fs372/en/
11. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Smith AH, Lingas EO, Rahman M, Bull World Health Organ 2000 78 1093 1103
12. Chronic arsenic toxicity in Bangladesh and West Bengal, India-a review and commentary. Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D, Biswas BK, Chanda CR, Basu GK, Saha KC, Roy S, Das R, Palit SK, Quamruzzaman Q, Chakraborti D, J Toxicol Clin Toxicol 2001 39 683 700 (Pubitemid 34016563)
13. Arsenic contamination in Bangladesh groundwater: a major environmental and social disaster. Alam MGM, Allinson G, Stagnitti F, Tanaka A, Westbrooke M, Int J Environ Health Res 2002 12 235 253
14. Chronic arsenic exposure and its adverse health effects in Taiwan: A paradigm for management of a global environmental problem. Lan C-C, Yu H-S, Ko Y-C, Kaohsiung J Med Sci 2011 27 411 416
15. Natural attenuation processes for remediation of arsenic contaminated soils and groundwater. Wang S, Mulligan CN, J Hazard Mater 2006 138 459 470 (Pubitemid 44679802)
16. WHO, United Nations Synthesis report on arsenic in drinking water Geneva, Switzerland: World Health Organization 2003
17. Arsenic concentrations in water, soil, milk and forage in Comarca Lagunera, Mexico. Rosas I, Belmont R, Armienta A, Baez A, Water Air Soil Pollut 1999 112 133 149 (Pubitemid 29230812)
18. Epidemiological studies on human subjects exposed to arsenic in drinking water in Southeast Hungary. Börzsönyi M, Bereczky A, Rudnai P, Csanady M, Horvath A, Arch Toxicol 1992 66 77 78
19. Arsenic in Nova Scotia groundwater. Meranger JC, Sci Total Environ 1984 39 49
20. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J, Environ Health Perspect 1999 107 705 710 (Pubitemid 29478879)
21. Inorganic arsenic in drinking water: an evolving public health concern. Lubin JH, Beane Freeman LE, Cantor KP, J Natl Cancer Inst 2007 99 906 907 (Pubitemid 47078728)
22. Arsenic exposure in US public and domestic drinking water supplies: A comparative risk assessment. Kumar A, Adak P, Gurian PL, Lockwood JR, J Expo Sci Environ Epidemiol 2009 20 3 245 254
23. IARC, A Review of Human Carcinogens. C. Metals, Arsenic, Fibres and Dusts Lyon: International Agency for Research on Cancer 2012 41 93
24. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: High-Arsenic Artesian well water and cancers. Chen C-J, Chuang Y-C, Lin T-M, Wu H-Y, Cancer Res 1985 45 5895 5899 (Pubitemid 16218606)
25. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Chen CJ, Chuang YC, You SL, Lin TM, Wu HY, Br J Cancer 1986 53 399 405
26. Arsenic and cancers. Chen CJ, Lancet 1988 1 414 415
27. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J, Am J Epidemiol 1989 130 1123 1132 (Pubitemid 20016349)
28. Ecological correlation between Arsenic level in well water and age-adjusted mortality from Malignant Neoplasms. Chen C-J, Wang C-J, Cancer Res 1990 50 5470 5474 (Pubitemid 20303006)
29. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Chiang HS, Guo HR, Hong CL, Lin SM, Lee EF, Br J Urol 1993 71 274 278 (Pubitemid 23102250)
30. Observations on the dose-response curve for arsenic exposure and lung cancer. Hertz-Picciotto I, Smith AH, Scand J Work Environ Health 1993 19 217 226
31. Case-control study of bladder cancer and arsenic in drinking water. Bates MN, Smith AH, Cantor KP, Am J Epidemiol 1995 141 523 530
32. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Chiou H-Y, Hsueh Y-M, Liaw K-F, Horng S-F, Chiang M-H, Pu Y-S, Shinn-Nan Lin J, Huang C-H, Chen C-J, Cancer Res 1995 55 1296 1300
33. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ, Am J Epidemiol 2001 153 411 418
34. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, Kishi Y, Aoyama H, Am J Epidemiol 1995 141 198 209
35. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH, Epidemiology 1996 7 117 124 (Pubitemid 26068042)
36. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Hopenhayn-Rich C, Biggs ML, Smith AH, Int J Epidemiol 1998 27 561 569 (Pubitemid 28431495)
37. Arsenic in drinking water and incidence of urinary cancers. Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR, Epidemiology 1997 8 545 550 (Pubitemid 27377271)
38. Cancer risk in an arsenic-contaminated area of Chile. Rivara MIZ, Cebrian MG, Corey G, Hernandez MA, Romieu I, Toxicol Ind Health 1997 13 321 338
39. Marked increase in bladder and lung cancer mortality in a region of northern Chile Due to arsenic in drinking water. Smith AH, Goycolea M, Haque R, Biggs ML, Am J Epidemiol 1998 147 660 669 (Pubitemid 28180309)
40. Drinking water arsenic in Utah: A cohort mortality study. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL, Environ Health Perspect 1999 107 359 365 (Pubitemid 29405841)
41. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Tsai SM, Wang TN, Ko YC, Arch Environ Health 1999 54 186 193
42. Lung cancer and arsenic exposure in drinking water: a case-control study in northern Chile. Ferreccio C, González Psych C, Milosavjlevic Stat V, Marshall Gredis G, Sancha AM, Cad Saude Publica 1998 14 Suppl 3 193 198
43. Risk of internal cancers from arsenic in drinking water. Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ, Environ Health Perspect 2000 108 655 661 (Pubitemid 30657871)
44. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Yang M-H, Chen K-K, Yen C-C, Wang W-S, Chang Y-H, Huang WJ-S, Fan FS, Chiou T-J, Liu J-H, Chen P-M, Urology 2002 59 681 687 (Pubitemid 34461977)
45. Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: evidence from a review of the literature. Khan MMH, Sakauchi F, Sonoda T, Washio M, Mori M, Asian Pac J Cancer Prev 2003 4 7 14
46. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan. Chiu H-F, Ho S-C, Yang C-Y, Lung Cancer 2004 46 265 270 (Pubitemid 39487300)
47. Cancer burden from arsenic in drinking water in Bangladesh. Chen Y, Ahsan H, Am J Public Health 2004 94 741 744 (Pubitemid 38560375)
48. Arsenic in drinking water: impact on human health. Hopenhayn C, Elements 2006 2 103 107 (Pubitemid 46769189)
49. Increased mortality from lung cancer and bronchiectasis in young adults following exposure to arsenic in utero and early childhood. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, Steinmaus C, Bates MN, Selvin S, Environ Health Perspect 2006 114(8) 8 1293 96 (Pubitemid 44184693)
50. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH, J Natl Cancer Inst 2007 99 920 928 (Pubitemid 47078729)
51. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Pu Y-S, Yang S-M, Huang Y-K, Chung C-J, Huang SK, Chiu AW-H, Yang M-H, Chen C-J, Hsueh Y-M, Toxicol Appl Pharmacol 2007 218 99 106 (Pubitemid 46177163)
52. Arsenic in drinking water and lung cancer: a systematic review. Celik I, Gallicchio L, Boyd K, Lam TK, Matanoski G, Tao X, Shiels M, Hammond E, Chen L, Robinson KA, Caulfield LE, Herman JG, Guallar E, Alberg AJ, Environ Res 2008 108 48 55
53. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Huang Y-K, Huang Y-L, Hsueh Y-M, Yang M-H, Wu M-M, Chen S-Y, Hsu L-I, Chen C-J, Cancer Causes Control 2008 19 829 839
54. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. Chung C-J, Huang C-J, Pu Y-S, Su C-T, Huang Y-K, Chen Y-T, Hsueh Y-M, Toxicol Appl Pharmacol 2008 226 14 21 (Pubitemid 350235580)
55. Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure. Fernández MI, López JF, Vivaldi B, Coz F, J Urol 2012 187 856 861
56. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis. Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS, Regul Toxicol Pharmacol 2008 52 299 310
57. Dietary intake of methionine, cysteine, and protein and urinary arsenic excretion in Bangladesh. Heck JE, Nieves JW, Chen Y, Parvez F, Brandt-Rauf PW, Graziano JH, Slavkovich V, Howe GR, Ahsan H, Environ Health Perspect 2009 117 99 104
58. Arsenic in drinking water and adult mortality. Sohel N, Persson LÅ Rahman M, Streatfield PK, Yunus M, Ekström E-C, Vahter M, Epidemiology 2009 20 824 830
59. Increased mortality associated with well-water arsenic exposure in Inner Mongolia, China. Wade TJ, Xia Y, Wu K, Li Y, Ning Z, Le XC, Lu X, Feng Y, He X, Mumford JL, Int J Environ Res Public Health 2009 6 1107 1123
60. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from Northeastern Taiwan. Chen C-L, Chiou H-Y, Hsu L-I, Hsueh Y-M, Wu M-M, Wang Y-H, Chen C-J, Cancer Epidemiol Biomarkers Prev 2010 19 101 110
61. Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M, Smith AH, Epidemiology 2010 21 103 108
62. Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina. Aballay LR, Dìaz M del P, Francisca FM, Muñoz SE, Int J Environ Health Res 2012 22 3 1 12
63. Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986-2006). Pou SA, Osella AR, Diaz MDP, Cancer Causes Control 2011 22 407 415
64. Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan. Su C-C, Lu J-L, Tsai K-Y, Lian I-B, Cancer Causes Control 2011 22 101 108
65. Urinary arsenic profiles and the risks of cancer mortality: A population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan. Chung C-J, Huang Y-L, Huang Y-K, Wu M-M, Chen S-Y, Hsueh Y-M, Chen C-J, Environ Res 2013 122 25 30
66. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Leonardi G, Vahter M, Clemens F, Goessler W, Gurzau E, Hemminki K, Hough R, Koppova K, Kumar R, Rudnai P, Surdu S, Fletcher T, Environ Health Perspect 2012 120 721 726
67. Drinking water arsenic in northern Chile: high cancer risks 40 years after exposure cessation. Steinmaus CM, Ferreccio C, Acevedo Romo J, Yuan Y, Cortes S, Marshall G, Moore LE, Balmes JR, Liaw J, Golden T, Smith AH, Cancer Epidemiol Biomarkers Prev 2013 22 4 623 630
68. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels-An exploration of the dose-response Poisson analysis. Lamm SH, Robbins S, Zhou C, Lu J, Chen R, Feinleib M, Regul Toxicol Pharmacol 2013 65 1 147 156
69. Bladder cancer and arsenic through drinking water: A systematic review of epidemiologic evidence. Christoforidou EP, Riza E, Kales SN, Hadjistavrou K, Stoltidi M, Kastania AN, Linos A, J Environ Sci Health A Tox Hazard Subst Environ Eng 2013 48 1764 1775
70. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY, Arteriosclerosis 1988 8 452 460
71. National Research Council, Critical Aspects of EPA's IRIS Assessment of Inorganic Arsenic: Interim Report Washington, DC: The National Academies Press 2014
72. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Karagas MR, Stukel TA, Tosteson TD, Int J Hyg Environ Health 2002 205 85 94 (Pubitemid 34288653)
73. IARC, Monographs on the Evaluation of Carcinogenic Risks to Human: Drinking Water Disinfectants and Contaminants, including Arsenic Lyon: International Agency for Research on Cancer 2007
74. Carcinogenic risks of inorganic arsenic in perspective. Byrd DM, Roegner ML, Griffiths JC, Lamm SH, Grumski KS, Wilson R, Lai S, Int Arch Occup Environ Health 1996 68 484 494 (Pubitemid 26315956)
75. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Kitchin KT, Toxicol Appl Pharmacol 2001 172 249 261 (Pubitemid 32406033)
76. Arsenic and urinary bladder cell proliferation. Luster MI, Simeonova PP, Toxicol Appl Pharmacol 2004 198 419 423 (Pubitemid 38969971)
77. Arsenic-induced bladder cancer in an animal model. Cohen SM, Ohnishi T, Arnold LL, Le XC, Toxicol Appl Pharmacol 2007 222 258 263 (Pubitemid 47198272)
78. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Andrew AS, Mason RA, Kelsey KT, Schned AR, Marsit CJ, Nelson HH, Karagas MR, Toxicol Lett 2009 187 10 14
79. Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells. Florea A-M, Büsselberg D, Toxicology Letters 2008 179 34 42
80. Induction of human squamous cell-type carcinomas by arsenic. Martinez VD, Becker-Santos DD, Vucic EA, Lam S, Lam WL, Journal of Skin Cancer 2011 2011 454157
81. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L, Environmental Health Perspectives 2011 119 11 11 19
82. The global burden of urinary bladder cancer. Parkin DM, Scand J Urol Nephrol Suppl 2008 218 12 20
83. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. Zeegers MA, Kellen E, Buntinx F, Brandt P, World J Urol 2004 21 392 401
84. The epidemiology of renal cell carcinoma. Lipworth L, Tarone RE, McLaughlin JK, J Urol 2006 176 2353 2358 (Pubitemid 44665976)
85. Epidemiology and risk factors of urothelial bladder cancer. Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, la Vecchia C, Shariat S, Lotan Y, Eur Urol 2012 176
86. Bladder cancer, a review of the environmental risk factors. Letašiová S, Medve'ová A, Šovčí ková A, Dušinská M, Volkovová K, Mosoiu C, Bartonová A, Environ Health 2012 11 Suppl 1 11
87. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Meliker JR, Slotnick MJ, Avruskin GA, Schottenfeld D, Jacquez GM, Wilson ML, Goovaerts P, Franzblau A, Nriagu JO, Cancer Causes Control 2010 21 5 745 757
88. Cancer incidence and high environmental arsenic concentrations in rural populations: results of an ecological study. Hinwood AL, Jolley DJ, Sim MR, Int J Environ Health Res 1999 9 131 141 (Pubitemid 29267945)
89. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S, Wilson R, J Occup Environ Med 2004 46 298 306 (Pubitemid 38366634)
90. Individual lifetime exposure to inorganic arsenic using a space-time information system. Meliker JR, Slotnick MJ, Avruskin GA, Kaufmann A, Fedewa SA, Goovaerts P, Jacquez GJ, Nriagu JO, Int Arch Occup Environ Health 2007 80 184 197 (Pubitemid 46139411)
91. Arsenic methylation and bladder cancer risk in Taiwan. Chen Y-C, Su H-JJ, Guo Y-LL, Hsueh Y-M, Smith TJ, Ryan LM, Lee M-S, Christiani DC, Cancer Causes Control 2003 14 303 310 (Pubitemid 36735098)
92. Case-control study of bladder cancer and drinking water arsenic in the western United States. Steinmaus C, Yuan Y, Bates MN, Smith AH, Am J Epidemiol 2003 158 1193 1201 (Pubitemid 37548789)
93. Case-control study of bladder cancer and exposure to arsenic in Argentina. Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, Steinmaus C, Smith AH, Am J Epidemiol 2004 159 381 389 (Pubitemid 38200772)
94. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A, Cancer Causes Control 2004 15 465 472 (Pubitemid 39060938)
95. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D, Am J Epidemiol 2004 160 853 859 (Pubitemid 39434769)
96. Arsenic in drinking-water and risk for cancer in Denmark. Baastrup R, Sørensen M, Balstrøm T, Frederiksen K, Larsen CL, Tjønneland A, Overvad K, Raaschou-Nielsen O, Environ Health Perspect 2008 116 231 237 (Pubitemid 351356731)
97. Dobson AJ, An introduction to generalized linear models USA: CRC Press 2 2010
98. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, Introduction to Meta-Analysis UK: John Wiley & Sons 2011
99. Efron B, Tibshirani RJ, An Introduction to the Bootstrap New York: Chapman & Hall 1994
100. A review on environmental factors regulating arsenic methylation in humans. Tseng C-H, Toxicol Appl Pharmacol 2009 235 338 350
101. R Development Core Team, R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Compuing 2011
102. Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. http://www.futuremedicine.com/doi/abs/10.2217/ 14622416.9.8.1113
103. Scientific Opinion on Arsenic in Food. EFSA Panel on contaminants in the Food Chain (CONTAM), EFSA Journal 2009 7 10 199 Italy
104. Arsenic exposure predicts bladder cancer survival in a US population. Kwong R, Karagas M, Kelsey K, Mason R, Tanyos S, Schned A, Marsit C, Andrew A, World J Urol 2010 28 487 492
105. Rice consumption contributes to arsenic exposure in US women. Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath V, Gandolfi AJ, Baker ER, Jackson BP, Folt CL, Karagas MR, Proc Natl Acad Sci 2011 108 51 20656 60
106. Beyond MEDLINE for literature searches. Conn VS, Isaramalai S, Rath S, Jantarakupt P, Wadhawan R, Dash Y, J Nurs Scholarsh 2003 35 177 182 (Pubitemid 38586662)
107. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, for the Meta-analysis Of Observational Studies in Epidemiology Group, JAMA 2000 283 2008 2012 (Pubitemid 30214957)